Ads
related to: target
Search results
Semler share price target cut by Lake Street Capital amid lackluster Q1 By Investing.com
Investing.com· 9 hours agoOn Wednesday, Lake Street Capital Markets adjusted its share price target for Semler Scientific...
Baird predicts steady growth for SAGE Therapeutics at $15 target By Investing.com
Investing.com· 2 hours agoBaird Equity Research has initiated coverage of SAGE Therapeutics Inc (NASDAQ:SAGE), assigning it a...
Piper Sandler maintains $75 target on GitLab shares, cites Duo Pro By Investing.com
Investing.com· 10 hours agoOn Wednesday, Piper Sandler affirmed its Overweight rating and a $75.00 price target for GitLab Inc...
Target Is Selling a 'Gorgeous' $30 Tote Bag That Looks So Similar to an Iconic Designer Style That's...
Parade via Yahoo News· 1 day agoParade aims to feature only the best products and services. If you buy something via one of our...
Nicola Sturgeon sorry 2025 A9 dualling target cannot be met
BBC News· 12 hours agoSturgeon says she is sorry a commitment to dual the A9 from Inverness to Perth by 2025 could not be...
CAVA Group shares target raised by JPMorgan on growth potential By Investing.com
Investing.com· 12 hours agoOn Wednesday, JPMorgan (NYSE:JPM) increased its price target for CAVA Group Inc (NYSE:CAVA) shares...
Okta (NASDAQ:OKTA) Beats Q1 Sales Targets, Next Quarter's Sales Guidance Is Optimistic
StockStory via Yahoo Finance· 2 hours agoIdentity management software maker Okta (OKTA) reported results ahead of analysts' expectations in...
MicroStrategy share target raised by Canaccord Genuity amid Bitcoin pump By Investing.com
Investing.com· 9 hours agoOn Wednesday, Canaccord Genuity maintained a Buy rating on MicroStrategy Incorporated (NASDAQ:MSTR)...
BofA raises ProKidney shares target on REACT prospects By Investing.com
Investing.com· 13 hours agoOn Wednesday, BofA Securities adjusted its price target for ProKidney Corp. (NASDAQ: PROK) shares,...
Baird predicts steady growth for SAGE Therapeutics at $15 target By Investing.com
Investing.com· 2 hours agoBaird Equity Research has initiated coverage of SAGE Therapeutics Inc (NASDAQ:SAGE), assigning it a...